Hani Jneid, MD Department of Internal Medicine, Cleveland Clinic
Holly L. Thacker, MD, FACP Head, Section of Women’s Health, Departments of General Internal Medicine and Obstetrics and Gynecology, Cleveland Clinic; Director of Women’s Health Track GIM Fellowship, Clinical Associate Professor of Medicine, Penn State University
Address: Holly L. Thacker, MD, FACP, Department of General Internal Medicine and Obstetrics and Gynecology, A91, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; thackeh@ccf.org
This paper discusses treatment information that is “off-label,” ie, not approved by the Food and Drug Administration for the indication under discussion.
ABSTRACT
Cardiovascular disease is responsible for more deaths in women each year than all other causes combined. Women have different cardiac presentations than men and are more likely to be underdiagnosed and undertreated for coronary artery disease. This article addresses gender-specific issues in prevention, diagnosis, and treatment of coronary artery disease.
